Logo Logo
Help
Contact
Switch Language to German

Vergalli, J.; Carlet, M.; Hoffmann, T.; Roth, M.; Zuber, J. and Jeremias, I. (2017): XIAP is an Attractive Therapeutic Target for all as Validated in Innovative Genetically Engineered Patient-Derived Xenograft Models. In: Annals of Hematology, Vol. 96: S74-S75

Full text not available from 'Open Access LMU'.

Actions (login required)

View Item View Item